This study leads to two possible conclusions about the role of galectin-2 dysregulations in the pathophysiology of GDM [71]—whether the increased galectin-2 expression is a reaction to the inflammatory state of GDM or if it contributes to its development [71]. The gene discussed is LGALS2; the disease is gestational diabetes.